Status:
COMPLETED
Levosimendan Versus Combination With Magnesium Sulphate on Spine Protection by NIRS in Infants Undergoing Coarctectomy
Lead Sponsor:
Dalia Saad Abd-El Kader
Collaborating Sponsors:
Cairo University
Conditions:
Aortic Coarctation
Eligibility:
All Genders
1-12 years
Phase:
PHASE4
Brief Summary
In pediatric patients ,undergoing elective surgical correction of aortic coarcatation one of our main concern is spinal cord protection .Our aim to study the protective effect of levosimendan versus i...
Detailed Description
Effect of levosimendan and its combination with magnesium sulphate infusion as spinal cord protection using NIRS values before Aortic cross clamp and 10,20 min after cross clamp till the end of surger...
Eligibility Criteria
Inclusion
- Age group ranging from 0 to 12 months of both sexes. Aortic coarcatation eligible for correction
Exclusion
- Parents or guardian refusal. Age more than12 months. Significant left ventricular dysfunction Patient with Heart block Patient with pre-existing CNS disorder eg seizure Patient with renal or hepatic dysfunction
Key Trial Info
Start Date :
February 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04330755
Start Date
February 4 2021
End Date
April 30 2023
Last Update
October 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sara ABD El-Salam
Cairo, Egypt, 12555